Filing Details
- Accession Number:
- 0001467154-19-000035
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-21 16:53:43
- Reporting Period:
- 2019-05-17
- Accepted Time:
- 2019-05-21 16:53:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1467154 | Novan Inc. | NOVN | Pharmaceutical Preparations (2834) | 204427682 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1765684 | M. John Gay | C/O Novan, Inc. 4105 Hopson Road Morrisville NC 27560 | Vp, Finance & Corp. Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-05-17 | 14,900 | $1.50 | 15,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported in column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.57, inclusive. The reporting person undertakes to provide to Novan, Inc., any security holder of Novan, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.